Content about Menopause

August 25, 2011

Amgen has launched an educational campaign that targets women with postmenopausal osteoporosis at increased risk for fractures.

THOUSAND OAKS, Calif. — Amgen has launched an educational campaign that targets women with postmenopausal osteoporosis at increased risk for fractures.

The drug maker said that to promote its Act 2 Reduce Fractures campaign, which is supported by American Bone Health, the Global Healthy Living Foundation and the Older Women's League, the company has tapped award-winning actress Blythe Danner, who was diagnosed with the disease, to encourage women to learn of the risk factors and ways to improve their condition.

August 10, 2011

Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

MIAMI — Soy isoflavone tablets do not appear to be associated with a reduction in bone loss or menopausal symptoms in women within the first five years of menopause, according to a report in the Aug. 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

May 5, 2011

A major depressive disorder treatment made by Pfizer significantly reduced the number and severity of moderate-to-severe hot flashes in postmenopausal women, compared with placebo, according to a new study.

WASHINGTON — A major depressive disorder treatment made by Pfizer significantly reduced the number and severity of moderate-to-severe hot flashes in postmenopausal women, compared with placebo, according to a new study.

March 2, 2011

A group of drug makers have sued Mylan over its attempt to gain Food and Drug Administration approval for a generic menopause drug, Mylan said Tuesday.

PITTSBURGH — A group of drug makers have sued Mylan over its attempt to gain Food and Drug Administration approval for a generic menopause drug, Mylan said Tuesday.

January 26, 2011

Smoking before menopause, especially prior to giving birth, may be associated with a modest increase in the risk of developing breast cancer, according to a report in the Jan. 24 issue of Archives of Internal Medicine.

CHICAGO — Smoking before menopause, especially prior to giving birth, may be associated with a modest increase in the risk of developing breast cancer, according to a report in the Jan. 24 issue of Archives of Internal Medicine.

October 7, 2010

A new women's health, whole soy germ-based nutritional supplement containing natural S-equol reduced the frequency...

September 14, 2010

The Food and Drug Administration has approved a new treatment for gout, a painful condition...

WASHINGTON The Food and Drug Administration has approved a new treatment for gout, a painful condition that affects 3 million adults in the United States.

The FDA announced the approval of Savient Pharmaceuticals’ Krystexxa (pegloticase), a biotech drug for people who have not responded to or tolerated conventional therapies.

September 6, 2010

Bayer Consumer Care on Tuesday introduced two new gender-specific multivitamins: One A Day Menopause Formula...

MORRISTOWN, N.J. Bayer Consumer Care on Tuesday introduced two new gender-specific multivitamins: One A Day Menopause Formula and One A Day Men’s Pro Edge.

 

One A Day Menopause Formula is a complete multivitamin formulated with soy isoflavones to help address hot flashes and mild mood changes.

 

June 30, 2010

Anglo-Swedish drug maker AstraZeneca has created a savings card for users of one of its...

May 19, 2010

Danish drug maker Novo Nordisk will remove 25 microgram doses of a treatment for atrophic...

May 17, 2010

A branded drug made by Teva Pharmaceutical Industries reduced the frequency of nighttime awakenings due...

March 2, 2010

Launching for spring 2010 at CVS/pharmacy and Duane Reade are the new Neovadiol Gf Day...

February 28, 2010

Bionorica announced its products’ representatives are featured in two episodes of the series “Healing Quest,”...